Indian stocks: Visit www.stage2stocks.com →

Arcadia Biosciences, Inc.

Stage 4 · Declining · week 42

As of Oct 22, 2026, Arcadia Biosciences is in Stage 4, the downtrend phase, now in week 42 (since Dec 26, 2025). It closed at $0.16, 96.0% below its 52-week high and below its 200-day average, which is falling.

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. More about the company

$0.16
+4.92% today
$389,810 · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is RKDA early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 41w
S2 19w
S4 43w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 41w → S1 6w → S2 6w → S3 9w → S2 19w → S3 5w → S4 6w → S1 4w → S2 9w → S3 3w → S4 11w → S1 4w → S4 43w current
Total tracked: 165 weeks across 13 stage runs.

RKDA among Packaged Foods56th of 65 by relative strength

All 65 →
Stocks in Packaged Foods ranked by relative strength, with stage and one-month change
#StockStageRS1M
1DARStage 2 · wk 1093−9.3%
2WESTStage 2 · wk 493+19.9%
3HLFStage 1 · wk 289+14.9%
4SENEBStage 2 · wk 3487−4.8%
5CENTStage 3 · wk 684+14.3%
6SENEAStage 2 · wk 3881−8.3%
7CENTAStage 3 · wk 681+13.6%
8SJMStage 2 · wk 1778+9.0%
…56RKDAStage 4 · wk 425−62.0%
vs 52W High
-96.0%
$0.15 lo$4.10 hi
96.0% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 42
1w13w26w
Week 42, extended decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-85.0%
200 DMA: $1.08 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.22x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-62.0%
3M
-74.7%
6M
-84.7%
YTD
-92.5%
1Y
-95.9%
Scan Membership
Breakout Watch
Latest: 2025-06-18
6 appearances in last 60 days. First seen: 2019-03-27.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 42 · Vol 0.22x
2026-10-21S4
Wk 42 · Vol 0.08x
2026-10-20S4
Wk 41 · Vol 0.11x
2026-10-19S4
Wk 41 · Vol 0.49x
2026-10-16S4
Wk 41 · Vol 0.42x
2026-10-15S4
Wk 41 · Vol 0.31x
2026-10-14S4
Wk 41 · Vol 20.42x
2026-10-13S4
Wk 40 · Vol 17.28x
2026-10-12S4
Wk 40 · Vol 0.63x
2026-10-09S4
Wk 40 · Vol 0.32x
2026-10-08S4
Wk 40 · Vol 0.17x
2026-10-07S4
Wk 40 · Vol 0.26x
Moving averages & range
50 DMA
$0.38
200 DMA
$1.08
52W High
$4.10
52W Low
$0.15
5D Low
$0.15
Resistance levels (recent highs)
20d High
$0.31
60d High
$0.72
120d High
$1.20
250d High
$4.10
Next resistance
+90.1%
to 20d High
ROE
-430.9%
Profit margin -234.5%
Dividend Yield
0.00%
P/B 0.6

Arcadia Biosciences: quick answers

What stage is Arcadia Biosciences in?

As of Oct 22, 2026, Arcadia Biosciences (RKDA) is in Stage 4, the downtrend phase. It entered Stage 4 on Dec 26, 2025 and is in week 42. What the four stages mean

Is Arcadia Biosciences in an uptrend?

No. Arcadia Biosciences is in a Stage 4 downtrend. It trades 85.0% below its 200-day average, which is falling.

How far is Arcadia Biosciences from its 52-week high?

Arcadia Biosciences closed at $0.16 on Oct 22, 2026, 96.0% below its 52-week high of $4.10. Its 52-week low is $0.15.

How has Arcadia Biosciences performed over the past year?

As of Oct 22, 2026, Arcadia Biosciences is down 95.9% over the past year and down 92.5% so far in 2026.

Which sector and industry is Arcadia Biosciences in?

Arcadia Biosciences is in the Packaged Foods industry, part of the Consumer Staples sector.

About this companyConsumer Staples· Packaged Foods

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.